Evicenter
MarkdownMedical informationP&T meetings
Ersodetug (RZ358)

Tumor hyperinsulinism

Manufacturer
Rezolute
Launch
Not announced
Last updated
140 sources

Section 1 of 6

Terms and abbreviations

1 evidence topic · 0 sources

AbbreviationTerm
AHFSAmerican Hospital Formulary Service
BLABiologics license application
CGMContinuous glucose monitoring
CIConfidence interval
CTComputed tomography
ECOGEastern Cooperative Oncology Group
ENDOAnnual meeting of the Endocrine Society
ENETSEuropean Neuroendocrine Tumor Society
ESMOEuropean Society for Medical Oncology
EUEuropean Union
EUSEndoscopic ultrasound
FDAU.S. Food and Drug Administration
GEP-NETGastroenteropancreatic neuroendocrine tumor
GLP-1Glucagon-like peptide-1
HIHyperinsulinism
HRHazard ratio
IGF-1Insulin-like growth factor 1
IGF-2, IGF-IIInsulin-like growth factor 2
INDInvestigational new drug application
INNInternational nonproprietary name
IVIntravenous
JNETSJapan Neuroendocrine Tumor Society
KATPATP-sensitive potassium channel
LARLong-acting release
MEN 1Multiple endocrine neoplasia type 1
mTORMechanistic target of rapamycin
NANETSNorth American Neuroendocrine Tumor Society
NICTHNon-islet cell tumor hypoglycemia
PETPositron emission tomography
PRRTPeptide receptor radionuclide therapy
SECU.S. Securities and Exchange Commission
SEERSurveillance, Epidemiology, and End Results Program
SMBGSelf-monitored blood glucose
SPECTSingle-photon emission computed tomography
UKUnited Kingdom
WHOWorld Health Organization